| | Whole group () | Total () | Subgroup | value | Serum IL-1B ≥ 20.3 ng/L () | Serum IL-1B < 20.3 ng/L () |
| Age, years | 57 (48.0, 66.0) | 55 (42.0, 62.0) | 56.5 (46.0, 62.0) | 50.5 (40.3, 63.0) | 0.356 | Gender, male | 279 (59.5) | 52 (59.1) | 24 (54.5) | 28 (63.6) | 0.386 | BMI, kg/m2 | 21.1 ± 3.6 | 21.4 ± 3.9 | 21.6 ± 4.1 | 21.3 ± 3.8 | 0.729 | Smoking history, yes, pulmonary underlying diseases | 144 (30.7) | 26 (29.5) | 11 (25.0) | 15 (34.1) | 0.350 | TB | Treated | 180 (38.4) | 40 (45.5) | 22 (50.0) | 18 (40.9) | 0.392 | Active | 87 (18.6) | — | — | — | — | NTM infection | 30 (6.4) | — | — | — | — | Other acute respiratory infections | 59 (12.6) | — | — | — | — | Lung abscess | 12 (2.6) | — | — | — | — | Cancers | 60 (12.8) | — | — | — | — | COPD | Stable | 212 (45.2) | 47 (53.4) | 24 (54.5) | 23 (52.3) | 0.831 | Acute | 53 (11.3) | — | — | — | — | Sarcoidosis | 34 (7.3) | 5 (5.7) | 2 (4.5) | 3 (6.8) | 1.000 | AIP | 12 (2.6) | — | — | — | — | Other ILD | 53 (11.3) | 4 (4.8) | 3 (6.8) | 1 (2.3) | 0.616 | Systemic comorbidities | DM | 53 (11.3) | 7 (8.0) | 3 (6.8) | 4 (9.1) | 1.000 | Hypertension | 60 (12.8) | 14 (15.9) | 6 (13.6) | 8 (18.2) | 0.560 | Cardiac diseases | 60 (12.8) | 9 (10.2) | 3 (6.8) | 6 (13.6) | 0.484 | Cerebrovascular diseases | 14 (2.98) | 2 (2.3) | 0 (0) | 2 (4.5) | 0.494 | Systemic CS therapy | 36 (7.7) | — | — | — | — | Systemic IS therapy | 32 (6.8) | — | — | — | — | Pulmonary surgery history | 38 (8.1) | 9 (10.2) | 2 (4.5) | 7 (15.9) | 0.157 | Symptoms | Cough | 460 (98.1) | 85 (96.6) | 44 (100) | 41 (93.2) | 0.241 | Sputum production | 455 (97.0) | 82 (93.2) | 42 (95.5) | 40 (90.9) | 0.676 | Hemosputum | 272 (58.0) | 45 (51.1) | 26 (59.1) | 19 (43.2) | 0.135 | Fever | 158 (33.7) | 19 (21.6) | 8 (18.2) | 11 (25.0) | 0.437 | Chest pain | 58 (12.36) | 5 (5.68) | 2 (4.5) | 3 (6.8) | 1.000 | Fatigue | 79 (16.8) | 4 (4.5) | 3 (6.8) | 1 (2.3) | 0.616 | Radiological features | Cavity | 235 (50.1) | 40 (45.5) | 27 (61.4) | 13 (29.5) | 0.003 | Aspergilloma | 212 (45.2) | 36 (40.9) | 25 (56.8) | 11 (25.0) | 0.002 | Bronchiectasis | 408 (87.0) | 83 (94.3) | 23 (52.3) | 23 (52.3) | 1.000 | Patch | 451 (96.2) | 82 (93.2) | 43 (97.7) | 39 (88.6) | 0.091 | Consolidation | 363 (77.4) | 60 (68.2) | 27 (61.4) | 33 (75.0) | 0.170 | Nodules | 332 (70.8) | 58 (65.9) | 31 (70.5) | 27 (61.4) | 0.368 | Tree-in-bud pattern | 85 (18.1) | 8 (9.1) | 3 (6.8) | 5 (11.4) | 0.713 | Atelectasis | 28 (6.0) | 3 (3.40) | 0 (0) | 3 (6.8) | 0.241 | Pleural effusion | 79 (16.8) | 8 (9.1) | 5 (11.4) | 3 (6.8) | 0.713 | Pleural thickening | 192 (40.9) | 39 (44.3) | 22 (50) | 17 (38.6) | 0.283 | Interstitial fibrosis | 53 (11.3) | 4 (4.8) | 2 (4.5) | 2 (4.5) | 1.000 | Lung volume reduction | 47 (10.0) | 6 (6.8) | 2 (4.5) | 4 (9.1) | 0.676 | GGO | 53 (11.3) | 8 (9.1) | 2 (4.5) | 6 (13.6) | 0.266 | Cavity diameter (cm) | 3.6 (2.6, 4.8) | 3.4 (2.1, 4.8) | 4.6 (2.8, 5.0) | 2.0 (1.6, 2.7) | 0.000 | Aspergilloma size (cm) | 2.4 (1.7, 3.3) | 1.8 (1.5, 3.5) | 2.5 (1.6, 3.8) | 1.5 (0.9, 1.9) | 0.006 | Cavity wall thickness (cm) | 0.7 (0.5, 1.0) | 0.7 (0.3, 1.1) | 0.9 (0.4, 1.2) | 0.4 (0.2, 0.7) | 0.023 | G test, positive | 95 (20.3) | 16 (18.2) | 9 (20.5) | 7 (15.9) | 0.580 | GM test, positive | Blood | 211 (45.0) | 43 (48.9) | 25 (56.8) | 18 (40.9) | 0.135 | BWF | 338 (72.1) | 60 (68.2) | 32 (72.7) | 28 (63.6) | 0.360 | Aspergillus antibody, positive | 276 (58.8) | 55 (62.5) | 25 (56.8) | 30 (68.2) | 0.271 | Culture proof | Sputum | 177 (37.7) | 32 (36.4) | 17 (38.6) | 15 (34.1) | 0.658 | BWF | 165 (35.2) | 32 (36.4) | 19 (43.2) | 13 (29.5) | 0.184 | Laboratory test result | ALB | 39.1 ± 5.7 | 38.9 ± 5.6 | 38.6 ± 4.9 | 39.1 ± 6.2 | 0.699 | WBC | 7.2 (5.4, 9.3) | 7.5 (5.3, 9.0) | 7.1 (5.1, 9.6) | 8.0 (5.4, 8.8) | 0.867 | CRP | 6.9 (2.7, 20.4) | 5.9 (2.1, 18.8) | 5.8 (2.0, 26.2) | 6.0 (2.4, 8.3) | 0.987 | ESR | 33.3 (16.4, 51.3) | 26.9 (11.8, 51.6) | 26.3 (11.5, 50.0) | 30.7 (12.2, 52.7) | 0.739 | Inflammatory cytokines (ng/l) | IL-1B | 26.1 (15.2, 50.6) | 20.3 (15.2, 42.3) | 42.2 (25.2, 57.6) | 15.2 (11.7, 17.3) | 0.000 | IL-2 | 144.9 (102.2, 193.1) | 110.9 (75.1, 159.8) | 112.5 (76.3, 161.1) | 101.0 (69.9, 147.3) | 0.413 | IL-5 | 39.2 (26.8, 62.3) | 37.7 (26.4, 61.5) | 46.8 (27.0, 62.4) | 32.8 (25.1, 50.1) | 0.090 | IL-6 | 45.6 (23.0, 94.8) | 39.8 (26.7, 73.9) | 56.0 (27.6, 77.2) | 33.9 (24.6, 66.6) | 0.123 | TNF-α | 52.3 (30.3, 96.1) | 53.6 (33.7, 90.0) | 65.4 (33.5, 96.0) | 46.5 (33.9, 79.4) | 0.174 | γ-IFN | 16.6 (11.6, 27.5) | 17.8 (11.8, 27.0) | 20.0 (11.9, 31.4) | 16.8 (11.7, 22.3) | 0.129 |
|
|